NIH-funded research R01 grant

Using big data to improve medication safety for pregnant patients

Official title: Big data apprOaches fOr Safe Therapeutics in Healthy Pregnancies (BOOST-HP)

Funded at Harvard Pilgrim Health Care, INC. · NIH-11082300 · Data updated 2026-11-12

This study is looking at how safe certain medications are for pregnant women by using advanced data analysis to quickly find important information, so that moms-to-be and their doctors can make better decisions about what medications to use.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Pilgrim Health Care, INC.
NIH-funded
Lab location1 site (Canton, UNITED STATES)
Project startAugust 29, 2022
Project endApril 30, 2026
Funding year2025
Award (this year)$613,261
NIH project number5R01HD110107-04
Project IDNIH-11082300 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include pregnant individuals who are currently using or considering medications during their pregnancy.

Less likely to help

Patients who are not pregnant or those who are not using any medications during pregnancy may not receive benefits from this research.

What this research studies

This research investigates the safety of medications used during pregnancy by leveraging big data analytics. It aims to accelerate the generation of evidence regarding the risks and benefits of these medications, which currently takes an average of 27 years. The approach involves data-mining techniques to identify potential safety signals and evaluate them in a structured manner. By focusing on vulnerable populations, the research seeks to provide more accurate and timely information for pregnant patients and their healthcare providers.

Why it matters

Potential benefit: If successful, this research could lead to safer medication use during pregnancy, ultimately improving health outcomes for both mothers and their babies.

How similar studies have gone: Previous research utilizing big data approaches in pharmacovigilance has shown promise, indicating that this methodology could yield significant insights into medication safety during pregnancy.

Where this research is happening

  • Harvard Pilgrim Health Care, INC.
    Canton, United States
    Active

Researchers

  • Principal investigator: Maro, Judith — Harvard Pilgrim Health Care, INC.
  • Study coordinator: Maro, Judith

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.